Dimensional Fund Advisors
CCCC icon

Dimensional Fund Advisors’s C4 Therapeutics CCCC Stock Holding History

Dimensional Fund Advisors’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
442,518
+146,038
+49% +$344K ﹤0.01% 2817
2025
Q4 		$566K Sell
296,480
-52,809
-15% -$125K ﹤0.01% 2953
2025
Q3 		$775K Sell
349,289
-82,599
-19% -$198K ﹤0.01% 2928
2025
Q2 		$617K Sell
431,888
-82,267
-16% -$120K ﹤0.01% 2957
2025
Q1 		$823K Sell
514,155
-9,776
-2% -$29.2K ﹤0.01% 2913
2024
Q4 		$1.89M Sell
523,931
-54,954
-9% -$273K ﹤0.01% 2801
2024
Q3 		$3.3M Sell
578,885
-40,227
-6% -$242K ﹤0.01% 2655
2024
Q2 		$2.86M Sell
619,112
-12,979
-2% -$77.4K ﹤0.01% 2667
2024
Q1 		$5.16M Buy
632,091
+516,583
+447% +$4M ﹤0.01% 2538
2023
Q4 		$654K Sell
115,508
-67,117
-37% -$153K ﹤0.01% 3000
2023
Q3 		$340K Sell
182,625
-80,759
-31% -$246K ﹤0.01% 3115
2023
Q2 		$724K Sell
263,384
-118,832
-31% -$382K ﹤0.01% 2991
2023
Q1 		$1.2M Buy
382,216
+2,434
+0.6% +$14.3K ﹤0.01% 2864
2022
Q4 		$2.24K Buy
379,782
+353,704
+1,356% +$2.93M ﹤0.01% 2695
2022
Q3 		$229K Buy
+26,078
New +$271K ﹤0.01% 3212

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's CCCC Position: Q1 2026 in Review

Dimensional Fund Advisors increased its C4 Therapeutics (CCCC) stake by 49% in Q1 2026, buying an estimated $344K and bringing the position to 442,518 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Dimensional Fund Advisors first reported a position in CCCC in Q3 2022 and has held it in 15 quarters since. The position peaked at $5.16M in Q1 2024. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Dimensional Fund Advisors held 442,518 shares of C4 Therapeutics worth $1.16M as of Q1 2026.
  • Dimensional Fund Advisors bought 146,038 C4 Therapeutics shares in Q1 2026, an estimated $344K.
  • C4 Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2817 holding.
  • Dimensional Fund Advisors first reported a position in C4 Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's C4 Therapeutics position peaked at $5.16M in Q1 2024.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.